Your browser doesn't support javascript.
loading
Molecular mechanisms of human IRE1 activation through dimerization and ligand binding.
Joshi, Amar; Newbatt, Yvette; McAndrew, P Craig; Stubbs, Mark; Burke, Rosemary; Richards, Mark W; Bhatia, Chitra; Caldwell, John J; McHardy, Tatiana; Collins, Ian; Bayliss, Richard.
Afiliação
  • Joshi A; Department of Biochemistry, University of Leicester, Leicester, United Kingdom.
  • Newbatt Y; Cancer Research UK Leicester Centre, University of Leicester, Leicester, United Kingdom.
  • McAndrew PC; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
  • Stubbs M; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
  • Burke R; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
  • Richards MW; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
  • Bhatia C; Department of Biochemistry, University of Leicester, Leicester, United Kingdom.
  • Caldwell JJ; Cancer Research UK Leicester Centre, University of Leicester, Leicester, United Kingdom.
  • McHardy T; Department of Biochemistry, University of Leicester, Leicester, United Kingdom.
  • Collins I; Cancer Research UK Leicester Centre, University of Leicester, Leicester, United Kingdom.
  • Bayliss R; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
Oncotarget ; 6(15): 13019-35, 2015 May 30.
Article em En | MEDLINE | ID: mdl-25968568
ABSTRACT
IRE1 transduces the unfolded protein response by splicing XBP1 through its C-terminal cytoplasmic kinase-RNase region. IRE1 autophosphorylation is coupled to RNase activity through formation of a back-to-back dimer, although the conservation of the underlying molecular mechanism is not clear from existing structures. We have crystallized human IRE1 in a back-to-back conformation only previously seen for the yeast homologue. In our structure the kinase domain appears primed for catalysis but the RNase domains are disengaged. Structure-function analysis reveals that IRE1 is autoinhibited through a Tyr-down mechanism related to that found in the unrelated Ser/Thr protein kinase Nek7. We have developed a compound that potently inhibits human IRE1 kinase activity while stimulating XBP1 splicing. A crystal structure of the inhibitor bound to IRE1 shows an increased ordering of the kinase activation loop. The structures of hIRE in apo and ligand-bound forms are consistent with a previously proposed model of IRE1 regulation in which formation of a back-to-back dimer coupled to adoption of a kinase-active conformation drive RNase activation. The structures provide opportunities for structure-guided design of IRE1 inhibitors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Endorribonucleases Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Endorribonucleases Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article